Humana has faced a series of shocks this year, including surprise jumps in expenses and a deterioration in crucial Medicare ...

Humana (NYSE:HUM) quickly fell 5% in premarket trading at least party amid some Cigna (CI) comments about share repurchases.

Former Humana CEO Bruce Broussard has joined venture capital ... Humana declined to comment on Broussard's new position Under his leadership, Humana upped its investments in the Medicare Advantage ...

Cigna — which is getting out of Medicare coverage altogether — appears to have little interest in stepping back into the fray by acquiring Humana ... president and CEO of Evernorth, said ...

which it has called "arbitrary", but the company has also acknowledged the new reality and admitted it needs to do better as a business. On the Q3 earnings call with analysts, Humana's CEO ...

Cigna shares jumped as much as 9.4%, the most intraday since December, at the New York market open Thursday. Humana’s stock lost as much as 3.9%. Bloomberg News reported this month that Cigna ...

LAS VEGAS—Longtime Humana CEO Bruce Broussard departed the company over the summer, and, now, he's made his next move. Broussard will join Define Ventures as a venture partner, the firm ...

Jay Asser is the CEO editor for HealthLeaders. Cigna and Humana have rekindled plans for a potential merger by holding informal, early-stage discussions, Bloomberg reported, citing people familiar ...

The implications of the new Medicare payout ... Friday that it had replaced CEO Karen Lynch, who was appointed in 2021, with CVS Caremark President David Joyner. Humana, meanwhile, is looking ...

Humana Together in Health plans offer a range of benefits, including dental, vision, and hearing coverage, transportation for medical appointments, and care manager support. A new feature to be ... Dr ...

Starting in 2013, he served as the CEO and president of Humana, among the largest U.S. publicly traded benefits providers. Over the course of Broussard’s decade-long tenure, Humana’s market ...

Humana Inc. issued a more optimistic 2024 forecast after third-quarter profit exceeded expectations, breaking with larger peers that have struggled to contain medical costs. Adjusted earnings of $ ...